期刊
ARTHRITIS RESEARCH & THERAPY
卷 6, 期 2, 页码 41-44出版社
BMC
DOI: 10.1186/ar1151
关键词
bias; cohort study; confounding; data banks; randomized controlled trial; rheumatoid arthritis
类别
资金
- NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR043584] Funding Source: NIH RePORTER
- NIAMS NIH HHS [AR43584, P01 AR043584] Funding Source: Medline
Observational databanks have inherent strengths and shortcomings. As in randomized controlled trials, poor design of these databanks can either exaggerate or reduce estimates of drug effectiveness and can limit generalizability. This commentary highlights selected aspects of study design, data collection and statistical analysis that can help overcome many of these inadequacies. An international metaRegister and a formal mechanism for standardizing and sharing drug data could help improve the utility of databanks. Medical journals have a vital role in enforcing a quality checklist that improves reporting.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据